Rebecca A. Enos
Emmes (United States) · 25 works · 2,360 citations · h-index 12
Top works
- Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System
- An International Ki67 Reproducibility Study
- An international study to increase concordance in Ki67 scoring
- The National Cancer Institute–American Society of Clinical Oncology Cancer Trial Accrual Symposium: Summary and Recommendations
- Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration
- Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program
- Recommendations for Collection and Handling of Specimens From Group Breast Cancer Clinical Trials
- Use of the National Cancer Institute Community Cancer Centers Program Screening and Accrual Log to Address Cancer Clinical Trial Accrual
- Pediatric transplantation of the kidney, liver and heart: Summary report
- Early-Phase Clinical Trials In The Community: Results From the National Cancer Institute Community Cancer Centers Program Early-Phase Working Group Baseline Assessment
- Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC)
- State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials—A Multidisciplinary Approach
- Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical Trials
- Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network
- Early success in narrowing age, gender, and racial disparities in clinical trial accrual: Targeted screening efforts through the National Cancer Institute Community Cancer Centers Program (NCCCP).
- Expanded access trial of tocilizumab in COVID19+hospitalized cancer patients
- Early-phase (EP) clinical trials (CTs) in the community: Results from the National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP) Early-Phase Working Group (EPWG) Baseline Assessment Study (BAS).
- Clinical trials referral resource. Targeted therapy in squamous cell cancers of the head and neck.
- Targeted Therapy in Squamous Cell Cancers of the Head and Neck
- Abstract PO-092: Expanded access trial of tocilizumab in COVID19+ hospitalized cancer patients